163 related articles for article (PubMed ID: 21324044)
1. In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients.
Zeitouni NC; Giordano CN; Kane JM
Dermatol Surg; 2011 Mar; 37(3):357-64. PubMed ID: 21324044
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell carcinoma: an unusual indication for isolated limb perfusion.
Ponte P; Moniz JV; Farricha V; Weinholtz JB
Dermatol Online J; 2008 Jul; 14(7):6. PubMed ID: 18718190
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion.
Gupta AS; Heinzman S; Levine EA
South Med J; 1998 Mar; 91(3):289-92. PubMed ID: 9521375
[TBL] [Abstract][Full Text] [Related]
4. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
[TBL] [Abstract][Full Text] [Related]
5. Isolated hyperthermic limb perfusion chemotherapy in Merkel cell tumour: a case report.
Dawson R; Williams OM; Mansel RE
J R Coll Surg Edinb; 1996 Aug; 41(4):255-6. PubMed ID: 8772077
[TBL] [Abstract][Full Text] [Related]
6. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
Duprat JP; Domingues AL; Coelho EG; Leal RM; Nishinari K; Neves RI
Eur J Surg Oncol; 2009 Jun; 35(6):568-72. PubMed ID: 19013049
[TBL] [Abstract][Full Text] [Related]
7. Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma.
Elhassadi E; Egan E; O'sullivan G; Mohamed R
Clin Lab Haematol; 2006 Aug; 28(4):279-81. PubMed ID: 16898971
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
[TBL] [Abstract][Full Text] [Related]
9. [Regional isolated perfusion: also applicable in elderly patients].
Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
12. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.
Thompson JF; Siebert GA; Anissimov YG; Smithers BM; Doubrovsky A; Anderson CD; Roberts MS
Br J Cancer; 2001 Jul; 85(2):157-65. PubMed ID: 11461070
[TBL] [Abstract][Full Text] [Related]
13. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
14. Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb infusion.
Grobmyer SR; Copeland EM; Hochwald SN
Am Surg; 2008 Dec; 74(12):1222-3; author reply 1223. PubMed ID: 19097544
[No Abstract] [Full Text] [Related]
15. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
[TBL] [Abstract][Full Text] [Related]
16. Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion.
Wood BC; Kleinpeter KP; Levine EA
Am Surg; 2007 Dec; 73(12):1291-2. PubMed ID: 18186393
[No Abstract] [Full Text] [Related]
17. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
[No Abstract] [Full Text] [Related]
18. Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.
Turaga KK; Beasley GM; Kane JM; Delman KA; Grobmyer SR; Gonzalez RJ; Letson GD; Cheong D; Tyler DS; Zager JS
Arch Surg; 2011 Jul; 146(7):870-5. PubMed ID: 21768436
[TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
Deroose JP; Eggermont AM; van Geel AN; Verhoef C
Curr Opin Oncol; 2011 Mar; 23(2):183-8. PubMed ID: 21150602
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
Lejeune FJ; Eggermont AM
J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
